Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
JAPAN / Science & Health
May 19, 2023
Scientists urge G7 leaders to improve vaccine access in developing countries
Advocates used the summit to push back against the pharmaceutical industry’s pressure to strengthen intellectual property rights.
Japan Times
JAPAN / Science & Health / FOCUS
May 18, 2023
Japan has a new vaccine research funding unit for future pandemics — is it up to the task?
The country lacked a sense of urgency to prepare for potential outbreaks — this lack of preparedness has had a lasting impact.
Japan Times
COMMENTARY / World
May 17, 2023
A breakthrough on Alzheimer's is closer than ever
Promising data could open the door to insurance coverage for expensive new Alzheimer's drugs, bringing them closer to patients.
Japan Times
COMMENTARY / World
May 17, 2023
Fentanyl will win the war on drugs
Instead of a hopeless struggle against the supply of fentanyl, the U.S. must focus on reducing demand and the harm.
Japan Times
JAPAN
May 14, 2023
Group of Seven health ministers vow greater cooperation on vaccine supplies
G7 health ministers say they will strengthen cooperation to ensure the rapid supply of vaccines and drugs based on lessons learned from the COVID-19 pandemic.
Japan Times
WORLD / Science & Health / FOCUS
May 9, 2023
Drugs developed to treat diabetes may offer new approach against Alzheimer's
Experts hope that by improving glucose metabolism, and tamping down inflammation in the entire body, they can slow progression of diseases like Alzheimer's and Parkinson's.
Japan Times
WORLD / Science & Health
May 5, 2023
Experimental Alzheimer's drug slowed disease by 35% in trial, Eli Lilly reports
The results provide what experts say is the strongest evidence yet that removing sticky amyloid plaques from the brain benefits patients with the fatal disease.
Japan Times
WORLD / Science & Health
May 4, 2023
First RSV vaccine caps 60-year search to stem pervasive lung illness
The U.S. Food and Drug Administration cleared GSK’s shot against respiratory syncytial virus on Wednesday. The product will go on sale in the coming weeks for older adults.
Japan Times
BUSINESS
May 1, 2023
Astellas to buy Iveric Bio for $5.9 billion to expand eyesight treatments
The deal marks the fifth major overseas acquisition by Astellas, Japan's third biggest drugmaker by sales, since 2019.
Japan Times
ASIA PACIFIC
Apr 30, 2023
Mystery middleman may offer clues to Indian-made cough syrup deaths
The deaths of more than 70 Gambian children from acute kidney Injury were linked by global health officials to cough syrups made in India.
Japan Times
COMMENTARY / World
Apr 21, 2023
Cancer vaccine hunt makes progress, finally
A small cancer drug study shows promise in deploying mRNA technology against melanoma, but fighting tumors is vastly more complex than tackling COVID-19.
Japan Times
WORLD
Apr 20, 2023
As U.S. Supreme Court pauses abortion pill case, what happens next?
A lower court order imposing significant restrictions on the distribution of the abortion drug mifepristone stems from a lawsuit brought by anti-abortion groups seeking to ban the pill.
Japan Times
COMMENTARY / World
Apr 19, 2023
Abortion pill rulings to impact pharmaceutical innovation
Bringing new drugs to market is already expensive and time-consuming. Undercutting the FDA will only make it harder.
Japan Times
WORLD / Science & Health
Apr 17, 2023
Moderna-Merck cancer vaccine plus Keytruda delays recurrence of skin cancer
The findings of the recent trial suggest that adding a personalized cancer vaccine to antibody-based immunotherapy could prolong the time patients have without death or the cancer's return.
Japan Times
WORLD / Politics
Apr 15, 2023
U.S. Supreme Court hits pause on abortion pill ban
The U.S. Supreme Court on Friday temporarily preserved access to a widely used abortion pill, in an 11th-hour ruling preventing lower court restrictions on the drug from coming into force.
Japan Times
COMMENTARY / World
Apr 12, 2023
Schizophrenia drug may offer much-needed progress
Late-stage data on a treatment in development by Karuna Therapeutics for schizophrenia show promise on sharply reducing harsh side effects.
Japan Times
WORLD
Apr 8, 2023
U.S. judge hands anti-abortion groups partial win in abortion pill challenge
The ruling said the challenge is substantially likely to succeed, with the justice saying that the U.S. Food and Drug Administration had ignored risks in approving the drug mifepristone.
Japan Times
COMMENTARY / World
Apr 5, 2023
Just how dangerous are India’s generic drugs? Very.
The red flags for Indian drugs have been there for years. The world deserves much better than contaminated medicine and children poisoned by cough syrup.
Japan Times
WORLD / Science & Health
Apr 4, 2023
Xanax and Adderall access is being blocked by secret drug limits in U.S.
Patients diagnosed with conditions like anxiety and sleep disorders have become caught in the crosshairs of America’s opioid crisis.
Japan Times
JAPAN
Mar 30, 2023
Japan’s COVID vaccine orders lacked solid estimate of demand, watchdog says
The health ministry failed to show enough grounds for its decision to procure a total of 882 million vaccine doses for the government-funded vaccination drive, the Board of Audit said.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?